Phoenix Neurological Associates, Ltd.
5090 N. 40th Street
Suite 250
Phoenix, AZ 85018

Phone: (602) 258-3354
Fax: (602) 258-3368

email Phoenix Neurological Associates (If you have an urgent medical issue, do not email; please call us instead.)

news

PNA forms new partnership with the Mayo Clinic Epilepsy Division. Read more

Phoenix Neurological Associates, LTD was just named one of seven international centers of Excellence for Guillan Barre and CIDP. Read more

Share |


Subcutaneous Natalizumab Injections in RRMS

Trial Status
Open for Enrollment

What is the Purpose of this Study?
Compare Subcutaneous injections to IV infusions of Natalizumab in patients with RRMS

Who is Eligible?
Patients 18-65 who are currently not on any immunosuppressive treatment and have never used Tysabri. Further inclusion and exclusion criteria will be explained in detail by the Study Coordinator.

What is Involved in this Study?
All subjects will receive either subcutaneous or IV natalizumab monthly. Patients will come to the clinic for exams and other study related procedures.

How long is the Study?
The study is approximately 18 months

For more information contact: Lynne E. Flynn, CCRC, study coordinator, at 602-258-2863 or lynneflynn@pnal.net